Navigation Links
DOT Therapy: Newest Breakthrough Technology in Laser Skin Resurfacing
Date:10/2/2008

- Dr. Robert Weiss, Director of Maryland Laser, Skin and Vein Institute, Introduces DOT Therapy to his practice -

BALTIMORE, Oct. 2 /PRNewswire/ -- Robert Weiss, M.D., board certified dermatologist, is among the first physicians in the U.S. to offer his patients DOT Therapy (Dermal Optical Thermolysis), the latest, state-of-the-art procedure in laser skin resurfacing. Dr. Weiss is an internationally renowned dermatologist, who is in private practice in Hunt Valley, Md. and is also Director, Maryland Laser, Skin and Vein Institute.

According to Dr. Weiss, "DOT Therapy is a highly effective tool for reversing signs of aging of the skin. The key is in the way the engineers have designed the laser application for the skin. And, skin numbing cream is all that is needed."

DOT Therapy has taken laser skin rejuvenation to a whole new level.

-- This new procedure precisely delivers CO2 laser energy targeting the

face, neck, decolletage, hand and arms, opening up whole new areas for

laser rejuvenation.

-- DOT Therapy effectively improves sun damage, brown spots, wrinkles, fine

lines, and acne scarring with little downtime or discomfort -- usually

in minutes.

-- Patients are pleased with the face and body skin tightening and

improvement of crepe skin.

-- The SmartXide DOT laser system has the unique capability to deliver a

customized pattern of tiny, micro-sized dots, rather than treating the

entire skin surface, so healing is fast.

DOT Therapy has been introduced through an alliance between Eclipsemed, Ltd., one of the country's leading aesthetic laser distributors, and DEKA, one of the world's largest laser manufacturers. The SmartXide DOT system is an advanced CO2 (carbon dioxide) laser. The CO2 laser is the most common type of laser used for skin resurfacing: thoroughly proven and tested. CO2 lasers of the past covered the entire surface of the skin, resulting in a significant amount of downtime to heal, discomfort for the patient and prolonged redness of the skin. In addition, the old CO2 lasers could not treat non-facial areas like the neck and decolletage easily because skin in these areas did not heal as well as the face. DOT Therapy has received clearance from the Food & Drug Administration.

For more information, please visit http://www.dottherapy.com or http://www.eclipsemed.com.

Press Contact: Wendy Maurice, wendy@trentandcompany.com

Marketing Contact: Michelle Peters, mpeters@eclipsemed.com


'/>"/>
SOURCE Eclipsemed, Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Pivotal National Trial Uses Newest Interventional Radiology Treatment to Bust Blood Clots in Legs
2. AHF Criticizes Tibotec Over Steep Price for Newest AIDS Drug, Etravirine
3. Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain
4. The University of Nottingham in the British Midlands Announces Breakthrough in Parkinsons Disease Research
5. Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data
6. Applisonix Announces Breakthrough in Ultrasound Technology for Hair Removal - Average Hair Reduction of 38% Following Initial Treatment
7. Breakthrough Large Scale Transfection Technology Accelerates Cell-Based Assay Development
8. Kingfisher Announces FDA 510(k) Clearance of Breakthrough KFH Energy for Chronic Pain Sufferers
9. Stem Cell Research Provides Medical Breakthrough to Repair Heart Cell Damage Created by a Heart Attack
10. Thermo Fisher Scientific Introduces Breakthrough in RNA-Interference Technology
11. AlphaMed Pharmaceuticals Announces Breakthrough in the Development of Recombinant Alpha 1-Antitrypsin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... FDA 510(k) clearance covers ... for urological and surgical applications Mauna ... Cellvizio®, the multidisciplinary confocal laser endomicroscopy (CLE) platform, ... US with the 12 th 510(k) clearance ... This new FDA clearance covers Confocal Miniprobes indicated ...
(Date:5/25/2016)... , Deutschland und GERMANTOWN, Maryland ... Zusammenarbeit mit Therawis bedient ... bei Brustkrebs   QIAGEN N.V. (NASDAQ: ... gab heute bekannt, eine Lizenz- und Entwicklungsvereinbarung mit ... Assays für die Onkologie eingegangen zu sein. Ein ...
(Date:5/25/2016)... IRVINE, Calif. , May 25, 2016 /PRNewswire/ ... of testing for their new reference materials that ... workflows from sample collection to analyses. The rapid ... the demand for researchers to have standard methods ... data being generated. Biases inherently exist at every ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... 27, 2016 , ... Beleza Medspa has initiated a new program ... is the first time that Coolsculpting is being used for for more than just ... ensure they meet the prescribed body-fat standard, measured by the circumference-based tape method. ...
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting at ... company to wait until March 2017 for an interest rate increase, according to Rajeev ... of Business. , “The Federal Open Market Committee (FOMC) dot charts are of interest ...
(Date:5/26/2016)... ... 2016 , ... Georgia State University College of Law is ... Answering to the increasing demand for curricular specializations, the Certificate in Intellectual Property ... land use law. ,  , “The demand for lawyers with specific knowledge in ...
(Date:5/26/2016)... ... 2016 , ... There are nearly 14.5 million people living with and beyond ... Sunday, June 5, 2016, communities around the world will gather to recognize these cancer ... Cancer Survivors Day® is an annual worldwide Celebration of Life that is held on ...
(Date:5/26/2016)... ... ... effort to provide hair restoration information to the widest possible audience, Dr. Parsa Mohebi is ... the app. Dr. Mohebi, the founder of Parsa Mohebi Hair Restoration, is making all of ... Mohebi says, “The positive response to the Snapchat videos we started last month has been ...
Breaking Medicine News(10 mins):